Application
Western blot analysis of BEST2 Antibody (C-term) in MDA-MB435,MDA-MB231 cell line lysates (35ug/lane).BEST2 (arrow) was detected using the purified Pab.Application
Formalin-fixed and paraffin-embedded human breast carcinoma with BEST2 Antibody (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | BEST2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | BEST2; VMD2L1; Bestrophin-2; Vitelliform macular dystrophy 2-like protein 1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | VMD2L1 |
|---|---|
| Alternative Names | BEST2 VMD2L1 Bestrophin-2 Vitelliform macular dystrophy 2-like protein 1 |
| Molecular Weight(MW) | 57139 Da |
| Function | Forms calcium-sensitive chloride channels. Permeable to bicarbonate |
| Tissue Specificity | Mainly confined to the retinal pigment epithelium and colon |
| Cellular Localization | Cell membrane; Multi-pass membrane protein. |
| Entrez Gene | 54831 |
|---|
Application
Western blot analysis of BEST2 Antibody (C-term) in MDA-MB435,MDA-MB231 cell line lysates (35ug/lane).BEST2 (arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human breast carcinoma with BEST2 Antibody (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
